ScoreWhy is Titan Biotech Ltd ?
1
Company has a Debt to Equity ratio (avg) of 0.02 times
2
Poor long term growth as Operating profit has grown by an annual rate -1.45% of over the last 5 years
3
With a growth in Net Profit of 53.57%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 4 consecutive quarters
- PBT LESS OI(Q) At Rs 10.92 cr has Grown at 47.77%
- DEBTORS TURNOVER RATIO(HY) Highest at 9.03 times
- NET SALES(Q) At Rs 59.17 cr has Grown at 27.25%
4
With ROE of 16.5, it has a Very Expensive valuation with a 9.1 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 103.78%, its profits have risen by 54% ; the PEG ratio of the company is 0.9
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Titan Biotech should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Titan Biotech for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Titan Biotech
103.78%
1.79
58.00%
Sensex
-9.29%
-0.69
13.52%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.69%
EBIT Growth (5y)
-1.45%
EBIT to Interest (avg)
28.25
Debt to EBITDA (avg)
0.23
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
1.19
Tax Ratio
28.18%
Dividend Payout Ratio
7.68%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
23.53%
ROE (avg)
19.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
49
Industry P/E
42
Price to Book Value
9.09
EV to EBIT
44.47
EV to EBITDA
39.06
EV to Capital Employed
8.93
EV to Sales
7.56
PEG Ratio
0.90
Dividend Yield
0.13%
ROCE (Latest)
18.17%
ROE (Latest)
16.46%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
PBT LESS OI(Q)
At Rs 10.92 cr has Grown at 47.77%
DEBTORS TURNOVER RATIO(HY)
Highest at 9.03 times
NET SALES(Q)
At Rs 59.17 cr has Grown at 27.25%
PBDIT(Q)
Highest at Rs 12.49 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 21.11%
PAT(Q)
Highest at Rs 10.86 cr.
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 1.87 cr
Loading Valuation Snapshot...
Here's what is working for Titan Biotech
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 10.92 cr has Grown at 47.77%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 10.86 cr has Grown at 58.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 59.17 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 59.17 cr has Grown at 27.25%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 12.49 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 21.11%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 10.92 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 10.86 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 9.03 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Titan Biotech
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 1.87 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
